Thermo Fisher Scientific is a global provider of bioprocessing technologies and bioproduction support for life science companies, biotechnology firms, and contract development and manufacturing organizations (CDMOs). Our integrated offerings address the full biologics manufacturing ecosystem, spanning upstream cell culture preparation and media formulation through downstream purification, viral inactivation, formulation, and bulk fill-finish. This breadth of capability aligns with the evolving outsourcing strategies that pharmaceutical and biotech organizations apply as they navigate complex development and production cycles.
Our portfolio brings together media, chemicals, buffers, process liquids, and chromatography technologies that support key bioprocess operations, including scalable cell expansion, capture and polish purification, sterile filtration, and quality control workflows. These solutions are developed for compatibility across multiple stages of biologics manufacturing — enabling smoother transitions from early process development into commercial bioproduction workflows frequently leveraged by CDMOs and contract manufacturers.
A central element of our bioproduction support is our cGMP chemical supply chain capabilities, designed to help outsourcing teams manage raw material sourcing and logistical complexity. By combining access to a broad network of chemical manufacturers with regional sourcing pathways, vendor-managed inventory options, and cGMP/GDP-compliant storage and labeling, bioprocess teams can align raw material supply with fluctuating project timelines and regulatory expectations. Our sampling, lot traceability, and compliant handling services support materials across multiple modalities and scales, helping satisfy the diverse needs of development and commercial manufacturing partners.
Within the Thermo Fisher bioproduction ecosystem, additional services support outsourced manufacturing operations, including QA/QC-aligned raw material inspection, virtual consignment, and distribution solutions that interface with commercial and clinical supply chains. These services help organizations coordinate complex supply strategies and support continuity of operations across global manufacturing footprints.
Core Capabilities Across the Bioproduction Workflow:
- cGMP chemical supply chain services, including global sourcing, procurement, inventory management, compliant storage, labeling, and sampling
- Media, supplements, feeds, buffer, and process liquid solutions
- Upstream cell expansion and culture systems for scalable production
- Downstream purification and chromatography platforms
- Viral inactivation and sterile filtration technologies
- Quality control testing support
- Bulk storage, fill-finish support, and single-use systems
- Professional support for process scale, quality, and regulatory compliance
Thermo Fisher supports biologics modalities across early development through scale-up and commercial production with integrated bioprocessing technologies and tailored supply chain offerings — aligned with the priorities of outsourced development and manufacturing partners navigating intricate regulatory and operational environments.
CONTACT INFORMATION
Thermo Fisher Scientific
7305 Executive Way
Frederick, MD 21704
UNITED STATES
Contact: Hunter Tuck
FEATURED SOLUTIONS
-
Optimize quality release by leveraging certified cleanrooms and enhance efficiency and maintain regulatory compliance through comprehensive sampling, custom labeling, and flexible shipping.
-
Maintain material quality and integrity with storage facilities compliant with ISO 9001, cGMP, and GDP standards. Features include real-time temperature control and HAZ-class segregation.
-
Effective inventory management ensures the quality and traceability of raw materials, supports regulatory compliance, and enables operational savings. Learn how to secure your supply chain and reduce stockouts.
-
Explore chemical probes that are selective small-molecule modulators of a protein’s function.
-
Grow and scale up your manufacturing with the right support, and choose from 92,000+ chemicals provided through an extensive global network of 3,500+ manufacturers.
-
Explore end-to-end solutions and products suited to your organization, whether for research and discovery or planning for scale to commercial manufacturing.
FEATURED INSIGHTS
-
Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.
-
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
-
Learn how to mitigate supply chain risks for industrial alcohols and ensure workplace safety through rigorous tracking and reporting protocols.
-
Avoid massive capital expenditures by optimizing supply chain logistics. Learn how off-site material sampling and just-in-time delivery reduce lead times from eight weeks to a single day.
-
Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization.
-
Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.
-
Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth.
-
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.